The Regensburg Center for Interventional Immunology (RCI), University Regensburg, Chair for Gene-Immuntherapy, Univ.-Prof. Abken is offering the European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry (EN-ACTI 2NG) program to Individuals willing to undergo a Fellowship program at the Institution.
This fellowship program aims to train students with expertise in development of new and improved T cell-mediated cancer immuno-therapies.
Applications Deadline: August 1st 2018
Type: PhD programme
Eligible Countries: International
- Applicants must have a masters degree in Biological Sciences, Chemistry, (Bio-)Physics, Engineering, Medical Sciences.
- Applicants must not have resided or carried out her/his main activity (work, studies, etc.) in Germany for more than 12 months in the 3 years immediately before the reference date
- Applicants must be proficient in English Language
How To Apply: Applicants can contact Prof. Dr. Abken before submitting their applications. Applications have to include a CV, including a valid e-mail address and telephone number, and should include a copy of their qualifying degree and obtained grades, a letter of motivation and 2 recommendation letters.
These documents should be sent in a single pdf file to the following e-mail addresses: hinrich.abken-a-uk-koeln.de, hinrich.abken-at-ukr.de and enacti2ng-at-cbm.csic.es.
After a first check of fulfillment of the EU-mandated eligibility criteria Prof Dr. Abken will contact individual applicants.
Visit The Official Website For More Information